Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
Recruiting · NCT06345027 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY) | Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Neoplasms by Site, T-cell leukemia, acute myeloid leukemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-09-16 | NCT06345027 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor College of Medicine | 267 |
| The Methodist Hospital Research Institute | 124 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Texas Children's Hospital | Houston | United States | 187 |
| The Methodist Hospital | Houston | United States | 8 |